Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Amgen
More »

  • Array Lays Off 50 after Amgen Diabetes Collaboration Ends
    it "received notification this week that Amgen has elected to end its glucokinase ... The partnership's end and the job cuts come 3-1/2 years after Array and Amgen announced ...
    8-8-2013
  • Novartis, Ensemble Therapeutics Launch Collaborations
    Such injectable candidates have also been developed by Amgen and Eli Lilly. According to Ensemble, its antagonists represent potential first-in-class, orally active, small molecule ...
    8-6-2013
  • Creative Acquisition in Biotech, Take Two
    in 2012 were, in descending order: Amgen, Gilead Sciences, Biogen Idec, Celgene, ... Examples For example, in 2012, Amgen acquired Micromet because of its oncology pipeline ...
    8-1-2013
  • What the Top 15 Biopharma CEOs Are Making
    ... 1 % Change: 10.8% Position on 2012 List: Not ranked #10. Robert A. Bradway Company: Amgen Full title: Chairman of the Board as of January 1, 2013; President and CEO as of May ...
    7-31-2013
  • Improving Preclinical Research
    Writing in Nature last March , a former Amgen executive and his academic colleague called for improvements to preclinical cancer research, noting that "clinical trials in oncology ...
    7-29-2013
  • Novo Nordisk Tops GEN List of Top 25 Biotech Companies
    So it's no surprise that they top our biotech company list." Right behind Novo Nordisk is Amgen (NASDAQ:AMGN) with a $78.7 billion market cap, Gilead Sciences (NASDAQ:GILD) at ...
    7-25-2013
  • Top 25 Biotech Companies of 2013
    .../27: 757,321,824 shares * price $26.08) % Change: 296.8% Position on 2012 List: #3 #2. Amgen 2013 Market Cap: $78.695 billion (4/24: 749,976,556 shares * price $104.93) 2012 Market ...
    7-15-2013
  • Pact Builds Amgen Cardiovascular Drug Presence, Could Net Servier...
    Amgen said today it obtained from Servier U.S. commercial rights to an oral cardiovascular ... a heart drug presence for Amgen and could potentially net Servier more than $50 million. ...
    7-9-2013
  • Xencor Licenses MAb Patent to Merck & Co.
    Xencor has entered into partnerships with Amgen, Boehringer Ingelheim, CSL, Janssen R&D, MorphoSys, Pfizer, and Human Genome Sciences, acquired last year by GlaxoSmithKline. Xencor ...
    7-2-2013
  • Onyx Spurns Amgen Offer, Pursues Its Own Deal
    than the unsolicited $120-per-share Amgen offer rejected by Onyx' board. "We are ... its own sale rather than by selling to Amgen, which offered about $10 billion or $120 ...
    7-1-2013
  • 10 Industry-Venture Fund Alliances
    ... January 9 #4. Novartis + Amgen Ventures + Atlas Ventures Total investment size: $265 million Atlas Venture Fund IX Purpose: Provide Amgen and Novartis with strategic ...
    6-20-2013
  • Amgen's Denosumab Gets FDA OK for Giant-Cell Tumor Of Bone
    months. "With today's Xgeva FDA approval, Amgen can offer a much-needed treatment option ... said Sean E. Harper, M.D., evp, R&D at Amgen. "Advances in our understanding of the ...
    6-14-2013
  • Top 20 Corporate Venture Funds
    ... Year established: 2011 #5. (tie) Amgen Ventures Resources: $200 million in two funds: Amgen Ventures I, a $100 million fund founded 2004; and Amgen Ventures II, a $100 million fund ...
    6-14-2013
  • Amgen, Cytokinetics Add Japan to Heart Failure Collaboration
    Amgen and Cytokinetics said today they will expand a seven-year-old collaboration by ... Amgen has a license to develop the Cytokinetics-discovered omecamtiv mecarbil, a small ...
    6-12-2013
  • Promising Phase III Results for Amgen Ovarian Cancer Candidate
    paclitaxel in recurrent ovarian cancer, Amgen today said its drug had met its primary ... arm vs. four months in the control arm, Amgen said, noting it expects to report overall ...
    6-12-2013

GEN Poll

More » Poll Results » Archive »

Top Paid Women in Biopharma

Do you think the women on our list of the 20 top paid women executives in biopharma are underpaid?

Suggest a Poll